Actelion (ALIOY.PK), Europe's biggest biotech company, posts encouraging results from a...

|About: Actelion Ltd. ADR (ALIOY)|By:, SA News Editor

Actelion (ALIOY.PK), Europe's biggest biotech company, posts encouraging results from a mid-stage clinical trial of ponesimod, a treatment for skin disease psoriasis, with 46% of patients suffering from moderate to severe chronic plaque psoriasis seeing a 75% improvement in an index for monitoring the disease at 16 weeks when treated with a 20 milligram dose.